ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,198 | +332.5% | 38,961 | +455.5% | 0.63% | +237.4% |
| Q4 2022 | $277 | -99.9% | 7,014 | +10.4% | 0.19% | -72.1% |
| Q3 2022 | $255,000 | -1.9% | 6,354 | -5.1% | 0.67% | +185.1% |
| Q1 2022 | $260,000 | +381.5% | 6,692 | +507.3% | 0.24% | +279.0% |
| Q3 2021 | $54,000 | -81.2% | 1,102 | -80.8% | 0.06% | -80.6% |
| Q4 2020 | $287,000 | +277.6% | 5,736 | +214.5% | 0.32% | +315.6% |
| Q3 2020 | $76,000 | +40.7% | 1,824 | +65.5% | 0.08% | +285.0% |
| Q2 2020 | $54,000 | – | 1,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |